Malin S. Nilsson
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia.
Journal: Therapeutic advances in hematology
Published: January 24, 2025
Consistency of the efficacy of immunotherapy with histamine dihydrochloride and low-dose interleukin-2 for relapse prevention in acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: December 24, 2024
Continuous map of early hematopoietic stem cell differentiation across human lifetime.
Journal: Nature communications
Published: May 03, 2024
Histamine dihydrochloride and low-dose interleukin-2 has anti-leukemic efficacy in NPM1-mutated and myelomonocytic/monocytic acute myeloid leukemia.
Journal: Haematologica
Published: March 22, 2024
Single-cell proteo-transcriptomic profiling reveals altered characteristics of stem and progenitor cells in patients receiving cytoreductive hydroxyurea in early-phase chronic myeloid leukemia.
Journal: Haematologica
Published: January 15, 2024
Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity.
Journal: Blood advances
Published: December 29, 2021
To embrace and be present: The lived experiences of nurse-led consultations in Sweden from the perspective of pediatric nurses.
Journal: Journal of pediatric nursing
Published: August 05, 2021
Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia.
Journal: British journal of haematology
Published: August 15, 2019
IFNL4 Genotypes Predict Clearance of RNA Viruses in Rwandan Children With Upper Respiratory Tract Infections.
Journal: Frontiers in cellular and infection microbiology
Published: July 03, 2019
Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype.
Journal: Human vaccines & immunotherapeutics
Published: June 27, 2019
Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis.
Journal: Oncoimmunology
Published: April 25, 2019
JAK-STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma.
Journal: International journal of cancer
Published: May 29, 2018
Last Updated: 09/26/2026